Surgical Outcomes of Spontaneously Ruptured Hepatocellular Carcinoma.
Carcinoma
Hepatectomy
Hepatocellular
Rupture
Spontaneous
Journal
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
ISSN: 1873-4626
Titre abrégé: J Gastrointest Surg
Pays: United States
ID NLM: 9706084
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
received:
27
07
2019
accepted:
18
02
2020
pubmed:
5
4
2020
medline:
20
4
2021
entrez:
5
4
2020
Statut:
ppublish
Résumé
Surgical and oncological outcomes in ruptured hepatocellular carcinoma (HCC) are not well known. The objective of this study was to review and compare survival outcomes and recurrence rates between ruptured and unruptured HCC. Data of patients with ruptured HCC who underwent curative surgical resection between January 2000 and December 2016 were retrospectively reviewed. To compare survival outcomes between ruptured and unruptured HCC, 1:2 individual matching was conducted. The 1-, 3-, and 5-year overall survival (OS) rates were 88.8%, 67.0%, and 51.9%, respectively. The 1-, 3-, and 5-year disease-free survival (DFS) rates were 51.7%, 32.8%, and 25.0%, respectively. OS and DFS rates were significantly lower in the ruptured HCC group than the matched unruptured HCC group. HCC recurred in 63 patients (70.8%), 33 (52.4%) of whom presented with both intrahepatic and extrahepatic recurrences. Mean recurrence interval was 12.6 ± 13.8 months. The 1-, 3-, and 5-year survival rates after recurrence were 61.6%, 40.2%, and 33.6%, respectively. Mean survival time after recurrence was 26.4 ± 29.5 months. Incidence of peritoneal seeding (PS) was 18.0%, and eight of them demonstrated solitary lesion. Mean recurrence interval was 5.9 ± 8.2 months. The 1-, 3-, and 5-year OS rates after recurrence were significantly lower in patients with PS (49.7%, 18.7%, and 9.3%, respectively) than in patients without PS. Hepatectomy in ruptured HCC did show worse survival outcome compared with unruptured HCC and bear a high risk of PS. However, surgical resection combined with transcatheter arterial chemoembolization could help in achieving acceptable oncological outcomes.
Sections du résumé
BACKGROUND
Surgical and oncological outcomes in ruptured hepatocellular carcinoma (HCC) are not well known. The objective of this study was to review and compare survival outcomes and recurrence rates between ruptured and unruptured HCC.
METHODS
Data of patients with ruptured HCC who underwent curative surgical resection between January 2000 and December 2016 were retrospectively reviewed. To compare survival outcomes between ruptured and unruptured HCC, 1:2 individual matching was conducted.
RESULTS
The 1-, 3-, and 5-year overall survival (OS) rates were 88.8%, 67.0%, and 51.9%, respectively. The 1-, 3-, and 5-year disease-free survival (DFS) rates were 51.7%, 32.8%, and 25.0%, respectively. OS and DFS rates were significantly lower in the ruptured HCC group than the matched unruptured HCC group. HCC recurred in 63 patients (70.8%), 33 (52.4%) of whom presented with both intrahepatic and extrahepatic recurrences. Mean recurrence interval was 12.6 ± 13.8 months. The 1-, 3-, and 5-year survival rates after recurrence were 61.6%, 40.2%, and 33.6%, respectively. Mean survival time after recurrence was 26.4 ± 29.5 months. Incidence of peritoneal seeding (PS) was 18.0%, and eight of them demonstrated solitary lesion. Mean recurrence interval was 5.9 ± 8.2 months. The 1-, 3-, and 5-year OS rates after recurrence were significantly lower in patients with PS (49.7%, 18.7%, and 9.3%, respectively) than in patients without PS.
CONCLUSIONS
Hepatectomy in ruptured HCC did show worse survival outcome compared with unruptured HCC and bear a high risk of PS. However, surgical resection combined with transcatheter arterial chemoembolization could help in achieving acceptable oncological outcomes.
Identifiants
pubmed: 32246392
doi: 10.1007/s11605-020-04555-0
pii: 10.1007/s11605-020-04555-0
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
941-953Références
Aoki T, Kokudo N, Matsuyama Y, Izumi N, Ichida T, Kudo M, Ku Y, Sakamoto M, Nakashima O, Matsui O, Makuuchi M, Liver Cancer Study Group of Japan. Prognostic impact of spontaneous tumor rupture in patients with hepatocellular carcinoma: an analysis of 1160 cases from a nationwide survey. Ann Surg 2014;259:532–542.
Cheung TT, Poon RT, Chok KS, Chan AC, Tsang SH, Dai WC, Yau TC, Chan SC, Fan ST, Lo CM. Management of spontaneously ruptured hepatocellular carcinomas in the radiofrequency ablation era. PLoS One 2014;9:e94453.
doi: 10.1371/journal.pone.0094453
Yang T, Sun YF, Zhang J, Lau WY, Lai EC, Lu JH, Shen F, Wu MC. Partial hepatectomy for ruptured hepatocellular carcinoma. Br J Surg 2013;100:1071–1079.
doi: 10.1002/bjs.9167
Kwak MS, Lee JH, Yoon JH, Yu SJ, Cho EJ, Jang ES, Kim YJ, Lee HS. Risk factors, clinical features, and prognosis of the hepatocellular carcinoma with peritoneal metastasis. Dig Dis Sci 2012;57:813–819.
doi: 10.1007/s10620-011-1995-1
Miyamoto M, Sudo T, Kuyama T. Spontaneous rupture of hepatocellular carcinoma: a review of 172 Japanese cases. Am J Gastroenterol 1991;86:67–71.
pubmed: 1846058
Hiraoka A, Kawamura T, Aibiki T, Okudaira T, Toshimori A, Yamago H, Nakahara H, Suga Y, Azemoto N, Miyata H, Miyamoto Y, Ninomiya T, Murakami T, Ishimaru Y, Kawasaki H, Hirooka M, Abe M, Matsuura B, Hiasa Y, Michitaka K. Prognosis and therapy for ruptured hepatocellular carcinoma: problems with staging and treatment strategy. Eur J Radiol 2015;84:366–371.
doi: 10.1016/j.ejrad.2014.11.038
Lai EC, Lau WY. Spontaneous rupture of hepatocellular carcinoma: a systematic review. Arch Surg 2006;141:191–198.
doi: 10.1001/archsurg.141.2.191
Yoshida H, Mamada Y, Taniai N, Uchida E. Spontaneous ruptured hepatocellular carcinoma. Hepatol Res 2016;46:13–21.
doi: 10.1111/hepr.12498
Schwarz L, Bubenheim M, Zemour J, Herrero A, Muscari F, Ayav A, Riboud R, Ducerf C, Regimbeau JM, Tranchart H, Lermite E, Petrovai G, Suhol A, Doussot A, Capussotti L, Tuech JJ, Le Treut YP, FRENCH association. Bleeding recurrence and mortality following interventional management of spontaneous HCC rupture: results of a multicenter European study. World J Surg 2018;42:225–232.
doi: 10.1007/s00268-017-4163-8
Zhu Q, Li J, Yan JJ, Huang L, Wu MC, Yan YQ. Predictors and clinical outcomes for spontaneous rupture of hepatocellular carcinoma. World J Gastroenterol 2012;18:7302–7307.
doi: 10.3748/wjg.v18.i48.7302
Zhu Q, Qiao GL, Xu C, Guo DL, Tang J, Duan R, Li Y. Partial hepatectomy for spontaneous tumor rupture in patients with hepatocellular carcinoma: a retrospective cohort study. Cancer Manag Res 2017;9:525–537.
doi: 10.2147/CMAR.S146708
Miyoshi A, Kitahara K, Kohya N, Noshiro H, Miyazahi K. Outcomes of patients with spontaneous rupture of hepatocellular carcinoma. Hepatogastroenterology 2011;58:99–102.
pubmed: 21510294
Chan AC, Dai JW, Chok KS, Cheung TT, Lo CM. Prognostic influence of spontaneous tumor rupture on hepatocellular carcinoma after interval hepatectomy. Surgery 2016;159:409–417.
doi: 10.1016/j.surg.2015.07.020
Liu CL, Fan ST, Lo CM, Tso WK, Poon RT, Lam CM, Wong J. Management of spontaneous rupture of hepatocellular carcinoma: single-center experience. J Clin Oncol 2001;19:3725–3732.
doi: 10.1200/JCO.2001.19.17.3725
Joliat GR, Labgaa I, Uldry E, Demartines N, Halkic N. Recurrence rate and overall survival of operated ruptured hepatocellular carcinomas. Eur J Gastroenterol Hepatol 2018;30:792–796.
doi: 10.1097/MEG.0000000000001115
Sada H, Ohira M, Kobayashi T, Tashiro H, Chayama K, Ohdan H. An analysis of surgical treatment for the spontaneous rupture of hepatocellular carcinoma. Dig Surg 2016;33:43–50.
doi: 10.1159/000441531
Tan FL, Tan YM, Chung AY, Cheow PC, Chow PK, Ooi LL. Factors affecting early mortality in spontaneous rupture of hepatocellular carcinoma. ANZ J Surg 2006;76:448–452.
doi: 10.1111/j.1445-2197.2006.03750.x
Tanaka S, Kaibori M, Ueno M, Wada H, Hirokawa F, Nakai T, Iida H, Eguchi H, Hayashi M, Kubo S. Surgical outcomes for the ruptured hepatocellular carcinoma: multicenter analysis with a case-controlled study. J Gastrointest Surg 2016;20:2021–2034.
doi: 10.1007/s11605-016-3280-2
Uchiyama H, Minagawa R, Itoh S, Kajiyama K, Harimoto N, Ikegami T, Yoshizumi T, Shirabe K, Takenaka K, Maehara Y. Favorable outcomes of hepatectomy for ruptured hepatocellular carcinoma: Retrospective analysis of primary R0-hepatectomized patients. Anticancer Res 2016;36:379–385.
pubmed: 26722069
Lee HS, Choi GH, Kang DR, Han KH, Ahn SH, Kim DY, Park JY, Kim SU, Choi JS. Impact of spontaneous hepatocellular carcinoma rupture on recurrence pattern and long-term surgical outcomes after partial hepatectomy. World J Surg 2014;38:2070–2078.
doi: 10.1007/s00268-014-2502-6
Liver Cancer Study Group of Japan. General rules for the clinical and pathological study of primary liver cancer. 6th Japanese ed. Tokyo: Kanehara & Co, 2015.
Kudo M, Kitano M, Sakurai T, Nishida N. General rules for the clinical and pathological study of primary liver cancer, nationwide follow-up survey and clinical practice guidelines: the outstanding achievements of the liver cancer study group of Japan. Dig Dis 2015;33:765–770.
doi: 10.1159/000439101
Amin MB, Edge SB, Greene FL, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR, American Joint Committee on Cancer, eds. AJCC cancer staging manual. 8th ed. New York: Springer, 2017.
doi: 10.1007/978-3-319-40618-3
Pombo F, Arrojo L, Perez-Fontan J. Haemoperitoneum secondary to spontaneous rupture of hepatocellular carcinoma: CT diagnosis. Clin Radiol 1991;43:321–322.
doi: 10.1016/S0009-9260(05)80539-2
Singhal M, Sinha U, Kalra N, Duseja A, Khandelwal N. Enucleation sign: a computed tomographic appearance of ruptured hepatocellular carcinoma. J Clin Exp Hepatol 2016;6:335–336.
doi: 10.1016/j.jceh.2016.05.004
Kim HC, Yang DM, Jin W, Park SJ. The various manifestations of ruptured hepatocellular carcinoma: CT imaging findings. Abdom Imaging 2008;33:633–642.
doi: 10.1007/s00261-007-9353-7
Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 2010;30:52–60.
doi: 10.1055/s-0030-1247132
Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, Sherman M, Schwartz M, Lotze M, Talwalkar J, Gores GJ, Panel of Experts in HCC-Design Clinical Trials. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 2008;100:698–711.
doi: 10.1093/jnci/djn134
Buczkowski AK, Kim PT, Ho SG, Schaeffer DF, Lee SI, Owen DA, Weiss AH, Chung SW, Scudamore CH. Multidisciplinary management of ruptured hepatocellular carcinoma. J Gastrointest Surg 2006;10:379–386.
doi: 10.1016/j.gassur.2005.10.012
The Korean Liver Cancer Association, National Cancer Center. Korea practice guidelines for management of hepatocellular carcinoma. 2018 [cited 2019 17 April]; Available from: http://livercancer.or.kr/study/guidelines.php .
Chen WK, Chang YT, Chung YT, Yang HR. Outcomes of emergency treatment in ruptured hepatocellular carcinoma in the ED. Am J Emerg Med 2005;23:730–736.
doi: 10.1016/j.ajem.2005.02.052
Zhang XF, Wei T, Liu XM, Lv Y. Spontaneous tumor rupture and surgical prognosis of patients with hepatocellular carcinoma. Scand J Gastroenterol 2012;47:968–974.
doi: 10.3109/00365521.2012.685753
Marini P, Vilgrain V, Belghiti J. Management of spontaneous rupture of liver tumours. Dig Surg 2002;19:109–113.
doi: 10.1159/000052022
Yoshida H, Mamada Y, Taniai N, Mizuguchi Y, Kakinuma D, Ishikawa Y, Kanda T, Matsumoto S, Bando K, Akimaru K, Tajiri T. Long-term results of elective hepatectomy for the treatment of ruptured hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2008;15:178–182.
doi: 10.1007/s00534-007-1239-0
Kow AW, Kwon CH, Song S, Shin M, Kim JM, Joh JW. Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma: review of 1222 cases of hepatectomy in a tertiary institution. Ann Surg Oncol 2012;19:2246–2255.
doi: 10.1245/s10434-012-2260-3
Yeh CN, Chen MF. Resection of peritoneal implantation of hepatocellular carcinoma after hepatic resection: risk factors and prognostic analysis. World J Surg 2004;28:382–386.
doi: 10.1007/s00268-003-7319-7
Ryu JK, Lee SB, Kim KH, Yoh KT. Surgical treatment in a patient with multiple implanted intraperitoneal metastases after resection of ruptured large hepatocellular carcinoma. Hepatogastroenterology 2004;51:239–242.
pubmed: 15011873
Yoshida H, Onda M, Tajiri T, Akimaru K, Takasaki H, Mamada Y, Taniai N, Nakamura Y, Kawano Y, Takahashi T. Successful surgical treatment of peritoneal dissemination of hepatocellular carcinoma. Hepatogastroenterology 2002;49:1663–1665.
pubmed: 12397759
Hung MC, Wu HS, Lee YT, Hsu CH, Chou DA, Huang MH. Intraperitoneal metastasis of hepatocellular carcinoma after spontaneous rupture: a case report. World J Gastroenterol 2008;14:3927–3931.
doi: 10.3748/wjg.14.3927
Tabrizian P, Franssen B, Jibara G, Sweeney R, Sarpel U, Schwartz M, Labow D. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with peritoneal hepatocellular carcinoma. J Surg Oncol 2014;110:786–790.
doi: 10.1002/jso.23739
Mehta S, Schwarz L, Spiliotis J, Hsieh MC, Akaishi EH, Goere D, Sugarbaker PH, Baratti D, Quenet F, Bartlett DL, Villeneuve L, Kepenekian V, Psogi, Big-Renape Working Groups. Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study. Eur J Surg Oncol 2018;44:1786–1792.
doi: 10.1016/j.ejso.2018.05.021
Mody K, Abou-Alfa GK. Systemic therapy for advanced hepatocellular carcinoma in an evolving landscape. Curr Treat Options Oncol 2019;20:3.
doi: 10.1007/s11864-019-0601-1